NYSE : ADCT
ADC Therapeutics SA — Financial statements
Healthcare · Biotechnology · Switzerland
Last price 1.53 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 195.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
ADC Therapeutics SA (ADCT) reported revenue of 79.58M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 79.58M | 81.36M | 70.84M | 69.56M | 209.91M | 33.92M |
| Cost of Revenue | 88.81M | 107.52M | 114.06M | 129.66M | 189.76M | 159.40M |
| Gross Profit | -9.23M | -26.16M | -43.23M | -60.10M | 20.15M | -125.48M |
| Selling, General & Admin | 84.83M | 79.93M | 85.91M | 105.89M | 143.49M | 136.24M |
| Operating Expenses | 84.83M | 79.93M | 85.91M | 105.89M | 143.49M | 136.24M |
| Operating Income | -94.06M | -106.09M | -129.14M | -165.99M | -123.34M | -261.72M |
| Interest Expense | -52.26M | -51.63M | -50.21M | -46.33M | -36.73M | -18.34M |
| Interest & Investment Income | 8.63M | 8.81M | 12.27M | 10.54M | 2.57M | 66.00K |
| Earnings From Equity Investments | -1.54M | -5.53M | -10.08M | -6.67M | ||
| Currency Exchange Gain (Loss) | 480.00K | -670.00K | -80.00K | -52.00K | -109.00K | 50.00K |
| Other Non Operating Income (Expenses) | 45.38M | 23.38M | 12.54M | 6.40M | 52.91M | 35.11M |
| EBT Excluding Unusual Items | -91.83M | -126.20M | -156.16M | -200.95M | -114.79M | -251.50M |
| Merger & Restructuring Charges | -9.12M | -13.12M | ||||
| Asset Writedown | 4.13M | -2.28M | -1.52M | |||
| Other Unusual Items | -500.00K | -42.11M | ||||
| Pretax Income | -97.31M | -141.61M | -157.68M | -200.95M | -156.90M | -251.50M |
| Income Tax Expense | -404.00K | 1.01M | 166.00K | 39.11M | 227.00K | -21.48M |
| Net Income | -96.91M | -142.62M | -157.85M | -240.05M | -157.13M | -230.03M |
| Net Income to Common | -96.91M | -142.62M | -157.85M | -240.05M | -157.13M | -230.03M |
| Shares Outstanding (Basic) | 149.11M | 127.07M | 97.16M | 81.71M | 78.15M | 76.75M |
| Shares Outstanding (Diluted) | 149.11M | 127.07M | 97.16M | 81.71M | 78.15M | 76.75M |
| EPS (Basic) | -0.65 | -1.12 | -1.62 | -2.94 | -2.01 | -3.00 |
| EPS (Diluted) | -0.65 | -1.12 | -1.62 | -2.94 | -2.01 | -3.00 |
| Free Cash Flow | -102.30M | -141.44M | -124.70M | -121.90M | -139.00M | -236.81M |
| Free Cash Flow Per Share | -0.69 | -1.11 | -1.28 | -1.49 | -1.78 | -3.09 |
| Gross Margin | -11.59% | -32.16% | -61.02% | -86.40% | 9.60% | |
| Operating Margin | -118.19% | -130.41% | -182.30% | -238.63% | -58.76% | -771.65% |
| Profit Margin | -121.77% | -175.31% | -222.83% | -345.11% | -74.86% | -678.20% |
| Free Cash Flow Margin | -128.55% | -173.85% | -176.04% | -175.25% | -66.22% | -698.20% |
| EBITDA | -93.71M | -105.39M | -127.80M | -164.80M | -122.28M | -260.75M |
| EBITDA Margin | -117.75% | -129.54% | -180.42% | -236.92% | -58.26% | |
| D&A For EBITDA | 353.50K | 705.00K | 1.33M | 1.19M | 1.06M | 970.00K |
| EBIT | -94.06M | -106.09M | -129.14M | -165.99M | -123.34M | -261.72M |
| EBIT Margin | -118.19% | -130.41% | -182.30% | -238.63% | -58.76% | |
| Revenue as Reported | 79.58M | 81.36M | 70.84M | 69.56M | 209.91M | 33.92M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 219.11M | 261.34M | 250.87M | 278.60M | 326.44M | 466.54M |
| Cash & Short-Term Investments | 219.11M | 261.34M | 250.87M | 278.60M | 326.44M | 466.54M |
| Accounts Receivable | 28.04M | 29.12M | 20.32M | 25.18M | 72.97M | 30.22M |
| Other Receivables | 1.93M | |||||
| Receivables | 28.04M | 29.12M | 20.32M | 25.18M | 72.97M | 32.14M |
| Inventory | 4.93M | 4.18M | 2.25M | 16.18M | 12.07M | 11.12M |
| Prepaid Expenses | 5.38M | 5.61M | 8.37M | 10.34M | 23.50M | 15.35M |
| Other Current Assets | 4.25M | 6.08M | 9.45M | 5.99M | 23.00K | |
| Total Current Assets | 261.71M | 306.33M | 291.25M | 336.29M | 434.98M | 525.18M |
| Property, Plant & Equipment | 1.10M | 1.30M | 13.43M | 16.13M | 10.26M | 11.23M |
| Long-Term Investments | 1.65M | 7.61M | 41.24M | |||
| Other Intangible Assets | 12.95M | |||||
| Long-Term Deferred Tax Assets | 37.10M | 26.05M | ||||
| Long-Term Deferred Charges | 631.00K | |||||
| Other Long-Term Assets | 16.57M | 15.52M | 17.30M | 711.00K | 902.00K | 693.00K |
| Total Assets | 279.38M | 323.15M | 321.98M | 354.78M | 490.86M | 617.97M |
| Accounts Payable | 12.76M | 9.18M | 18.03M | 15.57M | 12.35M | 12.08M |
| Accrued Expenses | 41.76M | 43.34M | 49.82M | 39.14M | 51.93M | 37.77M |
| Current Portion of Long-Term Debt | 27.27M | 3.00M | 13.39M | |||
| Current Portion of Leases | 538.00K | 1.37M | 1.47M | 1.10M | 1.03M | |
| Current Income Taxes Payable | 3.75M | |||||
| Other Current Liabilities | 4.55M | 14.11M | 11.25M | 11.50M | 16.56M | 5.92M |
| Total Current Liabilities | 86.33M | 70.16M | 80.47M | 67.67M | 81.94M | 73.94M |
| Long-Term Debt | 409.98M | 434.98M | 433.73M | 416.30M | 322.07M | 305.82M |
| Long-Term Leases | 946.00K | 1.03M | 8.00M | 10.18M | 6.56M | 6.99M |
| Long-Term Unearned Revenue | 23.54M | |||||
| Pension & Post-Retirement Benefits | 1.94M | 1.97M | 1.19M | 45.00K | 3.65M | |
| Other Long-Term Liabilities | 10.33M | 872.00K | 466.00K | 7.69M | 793.00K | 37.95M |
| Total Liabilities | 507.58M | 508.98M | 524.62M | 503.03M | 411.41M | 451.88M |
| Common Stock | 11.25M | 11.08M | 8.43M | 7.31M | 7.31M | 6.45M |
| Additional Paid-In Capital | 1.45B | 1.44B | 1.28B | 1.18B | 1.17B | 981.83M |
| Retained Earnings | -1.69B | -1.64B | -1.49B | -1.34B | -1.10B | -924.88M |
| Treasury Stock | -205.00K | -205.00K | -220.00K | -541.00K | -679.00K | -128.00K |
| Comprehensive Income & Other | -814.00K | -517.00K | -1.42M | -93.00K | 1.82M | 102.83M |
| Shareholders' Equity | -228.21M | -185.83M | -202.64M | -148.25M | 79.45M | 166.09M |
| Total Liabilities & Equity | 279.38M | 323.15M | 321.98M | 354.78M | 490.86M | 617.97M |
| Total Debt | 438.19M | 439.55M | 443.09M | 427.95M | 329.73M | 327.23M |
| Net Cash (Debt) | -219.08M | -178.21M | -192.22M | -149.35M | -3.29M | 139.32M |
| Net Cash Per Share | -1.47 | -1.40 | -1.98 | -1.83 | -0.04 | 1.82 |
| Filing Date Shares Outstanding | 127.67M | 127.04M | 99.08M | 82.53M | 80.64M | 76.81M |
| Total Common Shares Outstanding | 127.44M | 125.75M | 98.86M | 82.29M | 80.64M | 76.81M |
| Working Capital | 175.38M | 236.17M | 210.78M | 268.62M | 353.04M | 451.25M |
| Book Value Per Share | -1.79 | -1.48 | -2.05 | -1.80 | 0.99 | 2.16 |
| Tangible Book Value | -228.21M | -185.83M | -202.64M | -148.25M | 79.45M | 153.14M |
| Tangible Book Value Per Share | -1.79 | -1.48 | -2.05 | -1.80 | 0.99 | 1.99 |
| Machinery | 1.16M | 6.52M | 5.94M | 4.68M | 4.15M | |
| Leasehold Improvements | 225.00K | 3.87M | 3.95M | 2.08M | 2.25M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -96.91M | -142.62M | -157.85M | -240.05M | -157.13M | -230.03M |
| Depreciation & Amortization | 1.88M | 1.88M | 3.28M | 3.27M | 2.39M | 2.55M |
| Other Amortization | 2.14M | 1.82M | 902.00K | 3.02M | 3.35M | 79.00K |
| Asset Writedown & Restructuring Costs | 281.00K | 6.70M | ||||
| Loss (Gain) on Equity Investments | 1.54M | 5.53M | 10.08M | 6.67M | ||
| Stock-Based Compensation | 9.66M | 6.91M | 6.57M | 13.49M | 49.32M | 60.48M |
| Other Operating Activities | -15.47M | 9.51M | 17.89M | 51.79M | 2.40M | -57.42M |
| Change in Accounts Receivable | -1.84M | -8.79M | 4.77M | 47.79M | -42.75M | -30.22M |
| Change in Inventory | -4.64M | -2.38M | -3.73M | -5.71M | -9.65M | -3.02M |
| Change in Accounts Payable | 3.24M | -9.04M | 2.46M | 3.17M | 310.00K | 6.80M |
| Change in Income Taxes | 4.57M | |||||
| Change in Other Net Operating Assets | -611.00K | -5.15M | 321.00K | -979.00K | 3.37M | 6.16M |
| Operating Cash Flow | -102.27M | -141.17M | -123.83M | -118.69M | -138.31M | -233.38M |
| Capital Expenditures | -32.00K | -264.00K | -867.00K | -3.22M | -687.00K | -3.43M |
| Sale of Property, Plant & Equipment | 659.00K | 659.00K | ||||
| Sale (Purchase) of Intangibles | -2.95M | |||||
| Other Investing Activities | -297.00K | |||||
| Investing Cash Flow | 627.00K | 395.00K | -867.00K | -3.22M | -687.00K | -6.67M |
| Long-Term Debt Issued | 115.60M | 49.59M | ||||
| Long-Term Debt Repaid | -118.30M | -977.00K | ||||
| Lease Payments | -977.00K | |||||
| Net Debt Issued (Repaid) | -2.71M | 48.61M | ||||
| Issuance of Common Stock | 58.48M | 152.46M | 98.22M | 773.00K | 6.13M | 778.00K |
| Repurchase of Common Stock | -2.25M | -1.51M | -1.16M | -1.31M | ||
| Other Financing Activities | -20.00K | 73.10M | -3.00M | 218.00M | ||
| Financing Cash Flow | 56.21M | 150.94M | 97.05M | 73.88M | -897.00K | 267.39M |
| Foreign Exchange Rate Adjustments | -19.00K | 305.00K | -83.00K | 184.00K | -208.00K | 6.00K |
| Net Cash Flow | -45.45M | 10.47M | -27.73M | -47.84M | -140.10M | 27.35M |
| Free Cash Flow | -102.30M | -141.44M | -124.70M | -121.90M | -139.00M | -236.81M |
| Free Cash Flow Margin | -128.55% | -173.85% | -176.04% | -175.25% | -66.22% | -698.20% |
| Free Cash Flow Per Share | -0.69 | -1.11 | -1.28 | -1.49 | -1.78 | -3.09 |
| Levered Free Cash Flow | -68.12M | -103.81M | -70.85M | -79.93M | -72.93M | -141.90M |
| Unlevered Free Cash Flow | -37.60M | -73.36M | -40.37M | -53.99M | -53.33M | -130.43M |
| Free Cash Flow After Leases | -102.30M | -141.44M | -124.70M | -121.90M | -139.00M | -237.78M |
| Cash Interest Paid | 14.09M | 14.47M | 15.70M | 15.39M | 10.18M | 5.28M |
| Cash Income Tax Paid | 671.00K | |||||
| Change in Working Capital | -3.86M | -25.36M | 3.83M | 44.27M | -48.73M | -15.71M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 196.61M | 437.29M | 192.41M | 134.10M | 306.95M | 1.55B |
| Enterprise Value | 415.69M | 659.98M | 372.54M | 259.50M | 263.89M | 1.34B |
| Last Close Price | 1.54 | 3.53 | 1.99 | 1.66 | 3.84 | 20.20 |
| PS Ratio | 2.47 | 5.38 | 2.72 | 1.93 | 1.46 | 45.71 |
| PB Ratio | -2.35 | -0.95 | -0.91 | 3.86 | 9.34 | |
| P/TBV Ratio | 3.86 | 10.12 | ||||
| EV/Sales Ratio | 5.22 | 8.11 | 5.26 | 3.73 | 1.26 | 39.51 |
| Debt / Equity Ratio | -1.92 | -2.37 | -2.19 | -2.89 | 4.15 | 1.97 |
| Net Debt / Equity Ratio | -0.96 | -0.96 | -0.95 | -1.01 | 0.04 | -0.84 |
| Net Debt / EBITDA Ratio | -2.34 | -1.69 | -1.50 | -0.91 | -0.03 | 0.53 |
| Net Debt / FCF Ratio | -2.14 | -1.26 | -1.54 | -1.23 | -0.02 | 0.59 |
| Asset Turnover | 0.27 | 0.25 | 0.21 | 0.17 | 0.38 | 0.06 |
| Inventory Turnover | 7.83 | 33.42 | 12.38 | 9.18 | 16.36 | |
| Quick Ratio | 2.86 | 4.14 | 3.37 | 4.49 | 4.88 | 6.75 |
| Current Ratio | 3.03 | 4.37 | 3.62 | 4.97 | 5.31 | 7.10 |
| Return on Equity (ROE) | -127.99% | -91.72% | ||||
| Return on Assets (ROA) | -19.56% | -20.56% | -23.85% | -24.54% | -13.91% | -28.91% |
| Return on Capital Employed (ROCE) | -48.70% | -41.90% | -53.50% | -57.80% | -30.20% | -48.10% |
| Earnings Yield | -42.20% | -32.62% | -82.03% | -179.01% | -51.19% | -14.84% |
| FCF Yield | -52.03% | -32.34% | -64.81% | -90.91% | -45.28% | -15.27% |
| Buyback Yield / Dilution | -38.27% | -30.78% | -18.91% | -4.55% | -1.83% | -17.33% |